New Research Available: Global Molecular Diagnostics Market Report: 2013

MarketResearchReports.Biz announces addition of new report “Global Molecular Diagnostics Market Report: 2013 Edition” to its database


Albany, NY -- (SBWIRE) -- 07/24/2013 -- Human race has been persistently involved in a never ending pursuit for discovery and innovation in every field with a special inclination towards medical sciences. The perseverant efforts have triggered swift evolution in the realm of diagnostic tools and techniques.

To Read The Complete Report with TOC :

In-vitro diagnostic (IVD) tests are deployed for examining specimens including blood and tissues extracted from human body chiefly in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Under the IVD market falls the ‘Molecular Diagnostics’ sector which involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity.The molecular diagnostics procedures for infectious diseases including HPV, CT/NG; and the deadly gene linked cancer represent the largest market category in terms of revenue generation. Since the realm of cancer detection and screening procedures is undergoing a major change, the Oncology segment of the market is poised to undergo noteworthy expansion in the near future thereby driving the molecular diagnostics market on the holistic basis.

To Buy a Copy Of This Report:

As of now, the global molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of Oncology and reimbursement trend. While the global molecular diagnostics marketplace remains marred by challenges like rising price pressures and growing regulatory hurdles; the underlying growth drivers including the ever increasing demand for better healthcare solutions, coupled with ageing world population, reimbursement, increasing insurance density, growing demand for genetic testing and rising new incidences of cancer, are taking the molecular diagnostics market to new heights.

Latest Reports:

Breast Cancer Market Report: 2013 Edition

Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings. To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment. ‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed

Global ATM Market Report- 2013 Edition

Over the past years, automated teller machines (ATMs) have become a commonly accepted way to carry out varying transactions including withdrawal of cash, account deposits, balance updates, bill payments and bookings. The highest growth in the number of ATMs being installed has been recorded in Asia Pacific region driven by factors such as more cash in circulation, lower cost of ATM hardware, aggressive deployment of new technologies and desire for self-service. Countries like China, India and Indonesia offer a huge opportunity for ATM market as these are considered as cash growing markets with expanding middle class. Other regions like Middle East & Africa, Central and Eastern Europe also witnessed a moderate growth except North America that contracted in 2011. In developed markets l

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948